Sign in

CIK 0001576280

  • Large accelerated filer

Guardant Health, Inc.

Sign in to watch
Ticker
GH
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
454139254
Phone
+1 855-698-8887
Business address
3100 HANOVER STREET, PALO ALTO, CA, 94304
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,952,385
in 10 filings, $770K under 10b5-1 plans

Net −$3,952,385. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-01 Chudova Darya Chief Technology Officer Shares withheld for taxes −3,042 $42.55 $129K 73,023
2025-03-01 Chudova Darya Chief Technology Officer Exercise or conversion · Performance-Based Restricted Stock Units −5,686 11,376
2025-03-01 Chudova Darya Chief Technology Officer Exercise or conversion · Restricted Stock Units −315 632
2025-03-01 Bell Michael Brian Chief Financial Officer Exercise or conversion +7,108 40,285
2025-03-01 Bell Michael Brian Chief Financial Officer Shares withheld for taxes −2,537 $42.55 $108K 37,748
2025-03-01 Bell Michael Brian Chief Financial Officer Exercise or conversion · Performance-Based Restricted Stock Units −7,108 14,220
2025-02-28 Krognes Steve E. Director Exercise or conversion +154 10,528
2025-02-28 Krognes Steve E. Director Exercise or conversion · Restricted Stock Units −154 2,469
2025-02-20 Tariq Musa Director Sale 10b5-1 −116 $48.33 $6K 3,078
2025-02-15 Tariq Musa Director Exercise or conversion +250 3,194
2025-02-15 Tariq Musa Director Exercise or conversion · Restricted Stock Units −250 6,246
2018-10-09 SoftBank Group Capital Ltd 10% owner Conversion +2,033,990 2,033,990
2018-10-09 SoftBank Group Capital Ltd 10% owner Conversion · SERIES D PREFERRED STOCK −2,033,990 0

Page 57 of 57 · 1,133 trades